December 2014 FDA Recall Fluconazole by Baxter Healthcare Corp.
D-0380-2015 - Lack of Assurance of Sterility

This Class II drug recall was voluntarily initiated by Baxter Healthcare Corp. on December 23, 2014 for the product Fluconazole. The FDA reported the reason for recall as lack of assurance of sterility. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-0380-2015

Reason for Recall
Lack of Assurance of Sterility: Complaints of leaks due to an incomplete seal at the bag seam.
Initiated
12-23-2014
Reported
02-04-2015
Quantity
31,130 bags

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Baxter Healthcare Corp.
Nationwide, United Arab Emirates, and Columbia
Fluconazole Injection, USP, 200 mg/100 mL (2 mg/mL), 100 mL Single-Dose INTRAVIA Container bag, packaged in 10 x 100 mL Single Dose INTRAVIA container bags per carton, Rx only, Baxter Healthcare Corporation, Deerfield, IL 60015 USA, NDC 0338-6046-48, Product Code 2J1446.

Batch or Lot Expiration Information

Lot# : P318394; Exp 05/31/16

Affected Packages Involved in this Recall